Product
IDP-122
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion in Pediatric Subjects With Moderate to Severe Plaque PsoriasisStatus: Recruiting, Estimated PCD: 2024-06-01